Association of insulin resistance with hepatic steatosis and progression of fibrosis in Chinese patients with chronic hepatitis C

Hepato-Gastroenterology

Volumn 55, Issue 88, 2008, Pages 2157-2161

  Chu, Chi Jen ^a,b   Hung, Tsung Hsing ^a,b   Hwang, Shinn Jang ^a,b   Wang, Yuan Jen ^a,b   Yang, Ching Fen ^a,b   Lin, Han Chieh ^a,b   Lee, Fa Yauh ^a,b   Lu, Rei Hwa ^a   Chang, Chiao Yu ^a   Chang, Full Young ^a,b   Lee, Shou Dong ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Chronic hepatitis C; Fibrosis; Hepatic steatosis; HOMA IR; Insulin resistance; Platelet

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; FAT DROPLET;

ADULT; AGED; ARTICLE; BODY MASS; CHINESE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; FATTY LIVER; FEMALE; HEPATITIS C; HUMAN; HUMAN CELL; HUMAN TISSUE; INSULIN RESISTANCE; LIVER BIOPSY; LIVER CELL; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REFERENCE VALUE; SCORING SYSTEM; THROMBOCYTE COUNT;

ADULT; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; FEMALE; HEPATITIS C, CHRONIC; HUMANS; INSULIN RESISTANCE; LIVER CIRRHOSIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; YOUNG ADULT;

EID: 60849116159     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Allison ME, Wreghitt T, Palmer CR, Alexander GJ: Evidence for a link between hepatitis C virus infection and diabetes mellitus in a cirrhotic population. J Hepatol 1994; 21:1135-1139.
2. Ozyilkan E, Erbas T, Simsek H, Telatar F, Kayhan B, Telatar H: Increased prevalence of hepatitis C virus antibodies in patients with diabetes mellitus. J Intern Med 1994; 235:283-284.
3. Goodman ZD, Ishak KG: Histopathology of hepatitis C virus infection. Sem Liver Dis 1995;15:70-81.
4. Simo R, Hernandez C, Genesca J, Jardi R, Mesa J: High prevalence of hepatitis C virus infection in diabetic patients. Diabetes Care 1996; 19:998-1000.
5. Mehta SH, Brancati FL, Sulkowski MS, Strathdee SA, Szklo M, Thomas DL: Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States. Ann Intern Med 2000; 133:592-599.
6. DeFronzo RA: Lilly lecture 1987: The triumvirate: beta-cell, muscle, liver: A collusion responsible for NIDDM. Diabetes 1988; 37:667-687.
7. Cahill GF Jr: Beta-cell deficiency, insulin resistance, or both? N Engl J Med 1988; 318:1268-1270.
8. Warram JH, Martin BC, Krolewski AS, Soeldner JS, Kahn CR: Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents. Ann Intern Med 1990; 113:909-915.
9. Lillioja S, Mott DM, Howard BV, et al: Impaired glucose tolerance as a disorder of insulin action: Longitudinal and cross-sectional studies in Pima Indians. N Engl J Med 1988; 318:1217-1225.
10. Kawaguchi T, Yoshida T, Harada M, et al: Hepatitis C virus down-regulates insulin receptor substrates 1 and 2 through up-regulation of suppressor of cytokine signaling 3. Am J Pathol 2004; 165:1499-1508.
11. Hui JM, Sud A, Farrell GC, et al: Insulin resistance is associated with chronic hepatitis C and virus infection fibrosis progression. Gastroenterology 2003; 125:1695-1704.
12. Petit JM, Bour JB, Galland-Jos C, et al: Risk factors for diabetes mellitus and early insulin resistance in chronic hepatitis C. J Hepatol 2001; 35:279-283.
13. Fartoux L, Poujol-Robert A, Guechot J, Wendum D, Poupon R, Serfaty L: Insulin resistance in a cause of steatosis and fibrosis progression in chronic hepatitis C. Gut 2005; 54: 1003-1008.
14. Gamma C, Bruno S, Di Marco V, et al: Insulin resistance is associated with steatosis in nondiabetic patients with genotype 1 chronic hepatitis C. Hepatology 2006; 43:64-71.
15. Romero-Gomez M, Del Mar Viloria M, Andrade RJ, et al: Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients. Gastroenterology 2005; 128:636-641.
16. D'Souza R, Sabin CA, Foster GR: Insulin resistance plays a significant role in liver fibrosis in chronic hepatitis C and in the response to antiviral therapy. Am J Gastroenterol 2005; 100:1509-1515.
17. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28:412-419.
18. Ikeda Y, Suehiro T, Nakamura T, Kumon Y, Hashimoto K: Clinical significance of the insulin resistance index as assessed by homeostasis model assessment. Endocr J 2001; 48:81-86.
19. Stuyver L, Rossau R, Wyseur A, et al: Typing of hepatitis C virus isolates and characterization of new subtypes and using a line-probe assay. J Gen Virol 1993; 74:1093-1102.
20. French METAVIR Cooperative Study Group: Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. Hepatology 1994; 20:15-20.
21. Bedossa P, Poynard T: An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 1996; 24:289-293.
22. Nygren A, Adner N, Sundblad L, Wiechel KL: Insulin uptake by the human alcoholic cirrhotic liver. Metabolism 1985; 34:48-52.
23. Kruszynska YT, Home PD, McIntyre N: Relationship between insulin sensitivity, insulin secretion and glucose tolerance in cirrhosis. Hepatology 1991; 14:103-111.
24. Kaser S, Foger B, Waldenberger P, et al: Transjugular intrahepatic portosystemic shunt (TIPS) augments hyperinsulinemia in patients with cirrhosis. J Hepatol 2000; 33:902-906.
25. Hotamisligil GS, Murray DL, Choy LN, Spiegelman BM: Tumor necrosis factor alpha inhibits signaling from the insulin receptor. Proc Natl Acad Sci USA 1994; 91:4854-4858.
26. Shintani Y, Fujie H, Miyoshi H, et al. Hepatitis C infection and diabetes: direct involvement of the virus in the development of insulin resistance. Gastroenterology 2004; 126:840-848.
27. Aytug S, Reich D, Sapiro LE, Bernstein D, Begum N: Impaired IRS-1/ PI3-kinase signaling in patients with HCV: a mechanism for increased prevalence of type 2 diabetes. Hepatology 2003; 38:1384-1392.
28. Ueki K, Kondo T, Kahn CR: Suppressor of cytokine signaling 1 (SOCS-1) and SOCS-3 cause insulin resistance through inhibition of tyrosine phosphorylation of insulin receptor substrate proteins by discrete mechanisms. Mol Cell Biol 2004; 24:5434-5446.
29. Inoue H, Ogawa W, Ozaki M, et al: Role of STAT-3 in regulation of hepatic gluconeogenic genes and carbohydrate metabolism in vivo. Nat Med 2004; 10:168-174.
30. Moriya K, Yotsuyanagi H, Shintani Y, et al: Hepatitis C virus core protein induces hepatic steatosis in transgenic mice. J Gen Virol 1997; 78:1527-1531.
31. Okuda M, Li K, Beard MR, et al: Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein. Gastroenteology 2002; 122: 366-375.
32. Moriya K, Fujie H, Shintani Y, et al: The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Nat Med 1998; 4:1065-1067.
33. Lerat H, Honda M, Beard MR, et al: Steatosis and liver cancer in transgenic mice expressing the structural and non-structural proteins of hepatitis C virus. Gastroenterology 2002; 122:352-365.
34. Shulman GI: Cellular mechanisms of insulin resistance. J Clin Invest 2000;106:171-176.
35. Romero-Gomez M, Castellano-Megias VM, Grande L, et al: Serum leptin levels correlate with hepatic steatosis in chronic hepatitis C. Am J Gastroenterol 2003; 98:1135-1141.
36. Cohen B, Novick D, Rubinstein M: Modulation of insulin activities by leptin. Science 1996; 274:1185-1188.
37. Kumar D, Farrell GC, Fung C, George J: Hepatitis C virus genotype 3 is cytopathic to hepatocytes: Reversal of hepatic steatosis after sustained therapeutic response. Hepatology 2002; 86:1266-1272.
38. Poynard T, Ratziu V, McHutchison J, et al: Effect of treatment with peginterferon or interferon alfa-2b and ribavirin on steatosis in patients infected with hepatitis C. Hepatology 2003; 38:75-85.
39. Patton HM, Patel K, Behling C, et al: The impact of steatosis on disease progression and early and sustained treatment response in chronic hepatitis C patients. J Hepatol 2004; 40: 484-490.
40. Hui JM, Kanch J, Farrell GC, et al: Genotype specific mechanisms for hepatic steatosis in chronic hepatitis C infection. J Gastroenterol Hepatol 2002; 17:873-881.
41. Svegliati-Baroni G, Ridolfi F, Di Sario A, et al: Insulin and insulin-like growth factor-1 stimulate proliferation and type I collagen accumulation by human hepatic stellate cells: differential effects on signal transduction pathways. Hepatology 1999; 29:1743-1751.
42. Paradis V, Perlemuter G, Bonvoust F, et al: High glucose and hyperinsulinemia stimulate connective tissue growth factor expression: a potential mechanism involved in progression to fibrosis in nonalcoholic steatohepatitis. Hepatology 2001; 34:738-744.
43. Paradis V, Dargere D, Vidaud M, et al: Expression of connective tissue growth factor in experimental rat and human liver fibrosis. Hepatology 1999; 30:968-976.